Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms

Chiara Rapinesi, Delfina Janiri, Georgios D. Kotzalidis, Daniele Serata, Antonio Del Casale, Paola Scatena, Claudia Dacquino, Giovanna Gentile, Giovanni Manfredi, Emanuela Danese, Ruggero N essim Raccah, Roberto Brugnoli, Gemma Callovini, Vittoria R achele Ferri, Stefano Ferracuti, Abraham Zangen, Maurizio Simmaco, Gloria Angeletti, Paolo Girardi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND: Mitochondrial myopathies (MMs) often present with leukoencephalopathy and psychiatric symptoms, which do not respond to or worsen with psychiatric drugs.

CASE REPORT: A 67-year-old woman with a 10-year history of probable chronic progressive external ophthalmoplegia, an MM, had drug-resistant, anxious-depressive symptoms. Since she had never had seizures, we proposed 20 sessions of deep transcranial magnetic stimulation (dTMS) for her depression. Surprisingly, besides the expected improvement of depression, we observed marked improvement of movement disorder that lasted as long as the patient was undergoing dTMS. She also improved her performance on neuropsychological tests of executive function and cognitive speed. Depressive symptom improvement was persistent, while anxiety symptoms recurred after the end of the sessions.

CONCLUSIONS: dTMS may be an alternative antidepressant strategy in patients with MMs, provided that they are free from seizures. The mechanism of improvement of motor disturbance may relate to dorsolateral prefrontal cortex stimulation and improved executive function and needs further investigation.

Original languageEnglish
JournalGeneral Hospital Psychiatry
Volume37
Issue number3
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Mitochondrial Myopathies
Transcranial Magnetic Stimulation
Major Depressive Disorder
Gait
Depression
Executive Function
Psychiatry
Seizures
Chronic Progressive External Ophthalmoplegia
Leukoencephalopathies
Neuropsychological Tests
Movement Disorders
Prefrontal Cortex
Pharmaceutical Preparations
Antidepressive Agents
Anxiety

Keywords

  • Comorbidity
  • Deep transcranial magnetic stimulation (dTMS)
  • Dorsolateral prefrontal cortex (DLPFC)
  • Major depressive disorder
  • Mitochondrial myopathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mitochondrial myopathy and comorbid major depressive disorder : effectiveness of dTMS on gait and mood symptoms. / Rapinesi, Chiara; Janiri, Delfina; Kotzalidis, Georgios D.; Serata, Daniele; Del Casale, Antonio; Scatena, Paola; Dacquino, Claudia; Gentile, Giovanna; Manfredi, Giovanni; Danese, Emanuela; Raccah, Ruggero N essim; Brugnoli, Roberto; Callovini, Gemma; Ferri, Vittoria R achele; Ferracuti, Stefano; Zangen, Abraham; Simmaco, Maurizio; Angeletti, Gloria; Girardi, Paolo.

In: General Hospital Psychiatry, Vol. 37, No. 3, 01.05.2015.

Research output: Contribution to journalArticle

Rapinesi, C, Janiri, D, Kotzalidis, GD, Serata, D, Del Casale, A, Scatena, P, Dacquino, C, Gentile, G, Manfredi, G, Danese, E, Raccah, RNE, Brugnoli, R, Callovini, G, Ferri, VRA, Ferracuti, S, Zangen, A, Simmaco, M, Angeletti, G & Girardi, P 2015, 'Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms', General Hospital Psychiatry, vol. 37, no. 3. https://doi.org/10.1016/j.genhosppsych.2015.03.002
Rapinesi, Chiara ; Janiri, Delfina ; Kotzalidis, Georgios D. ; Serata, Daniele ; Del Casale, Antonio ; Scatena, Paola ; Dacquino, Claudia ; Gentile, Giovanna ; Manfredi, Giovanni ; Danese, Emanuela ; Raccah, Ruggero N essim ; Brugnoli, Roberto ; Callovini, Gemma ; Ferri, Vittoria R achele ; Ferracuti, Stefano ; Zangen, Abraham ; Simmaco, Maurizio ; Angeletti, Gloria ; Girardi, Paolo. / Mitochondrial myopathy and comorbid major depressive disorder : effectiveness of dTMS on gait and mood symptoms. In: General Hospital Psychiatry. 2015 ; Vol. 37, No. 3.
@article{9d52044f76054aa7b38850151c2de9ff,
title = "Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms",
abstract = "BACKGROUND: Mitochondrial myopathies (MMs) often present with leukoencephalopathy and psychiatric symptoms, which do not respond to or worsen with psychiatric drugs.CASE REPORT: A 67-year-old woman with a 10-year history of probable chronic progressive external ophthalmoplegia, an MM, had drug-resistant, anxious-depressive symptoms. Since she had never had seizures, we proposed 20 sessions of deep transcranial magnetic stimulation (dTMS) for her depression. Surprisingly, besides the expected improvement of depression, we observed marked improvement of movement disorder that lasted as long as the patient was undergoing dTMS. She also improved her performance on neuropsychological tests of executive function and cognitive speed. Depressive symptom improvement was persistent, while anxiety symptoms recurred after the end of the sessions.CONCLUSIONS: dTMS may be an alternative antidepressant strategy in patients with MMs, provided that they are free from seizures. The mechanism of improvement of motor disturbance may relate to dorsolateral prefrontal cortex stimulation and improved executive function and needs further investigation.",
keywords = "Comorbidity, Deep transcranial magnetic stimulation (dTMS), Dorsolateral prefrontal cortex (DLPFC), Major depressive disorder, Mitochondrial myopathy",
author = "Chiara Rapinesi and Delfina Janiri and Kotzalidis, {Georgios D.} and Daniele Serata and {Del Casale}, Antonio and Paola Scatena and Claudia Dacquino and Giovanna Gentile and Giovanni Manfredi and Emanuela Danese and Raccah, {Ruggero N essim} and Roberto Brugnoli and Gemma Callovini and Ferri, {Vittoria R achele} and Stefano Ferracuti and Abraham Zangen and Maurizio Simmaco and Gloria Angeletti and Paolo Girardi",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.genhosppsych.2015.03.002",
language = "English",
volume = "37",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Mitochondrial myopathy and comorbid major depressive disorder

T2 - effectiveness of dTMS on gait and mood symptoms

AU - Rapinesi, Chiara

AU - Janiri, Delfina

AU - Kotzalidis, Georgios D.

AU - Serata, Daniele

AU - Del Casale, Antonio

AU - Scatena, Paola

AU - Dacquino, Claudia

AU - Gentile, Giovanna

AU - Manfredi, Giovanni

AU - Danese, Emanuela

AU - Raccah, Ruggero N essim

AU - Brugnoli, Roberto

AU - Callovini, Gemma

AU - Ferri, Vittoria R achele

AU - Ferracuti, Stefano

AU - Zangen, Abraham

AU - Simmaco, Maurizio

AU - Angeletti, Gloria

AU - Girardi, Paolo

PY - 2015/5/1

Y1 - 2015/5/1

N2 - BACKGROUND: Mitochondrial myopathies (MMs) often present with leukoencephalopathy and psychiatric symptoms, which do not respond to or worsen with psychiatric drugs.CASE REPORT: A 67-year-old woman with a 10-year history of probable chronic progressive external ophthalmoplegia, an MM, had drug-resistant, anxious-depressive symptoms. Since she had never had seizures, we proposed 20 sessions of deep transcranial magnetic stimulation (dTMS) for her depression. Surprisingly, besides the expected improvement of depression, we observed marked improvement of movement disorder that lasted as long as the patient was undergoing dTMS. She also improved her performance on neuropsychological tests of executive function and cognitive speed. Depressive symptom improvement was persistent, while anxiety symptoms recurred after the end of the sessions.CONCLUSIONS: dTMS may be an alternative antidepressant strategy in patients with MMs, provided that they are free from seizures. The mechanism of improvement of motor disturbance may relate to dorsolateral prefrontal cortex stimulation and improved executive function and needs further investigation.

AB - BACKGROUND: Mitochondrial myopathies (MMs) often present with leukoencephalopathy and psychiatric symptoms, which do not respond to or worsen with psychiatric drugs.CASE REPORT: A 67-year-old woman with a 10-year history of probable chronic progressive external ophthalmoplegia, an MM, had drug-resistant, anxious-depressive symptoms. Since she had never had seizures, we proposed 20 sessions of deep transcranial magnetic stimulation (dTMS) for her depression. Surprisingly, besides the expected improvement of depression, we observed marked improvement of movement disorder that lasted as long as the patient was undergoing dTMS. She also improved her performance on neuropsychological tests of executive function and cognitive speed. Depressive symptom improvement was persistent, while anxiety symptoms recurred after the end of the sessions.CONCLUSIONS: dTMS may be an alternative antidepressant strategy in patients with MMs, provided that they are free from seizures. The mechanism of improvement of motor disturbance may relate to dorsolateral prefrontal cortex stimulation and improved executive function and needs further investigation.

KW - Comorbidity

KW - Deep transcranial magnetic stimulation (dTMS)

KW - Dorsolateral prefrontal cortex (DLPFC)

KW - Major depressive disorder

KW - Mitochondrial myopathy

UR - http://www.scopus.com/inward/record.url?scp=84965175474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965175474&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2015.03.002

DO - 10.1016/j.genhosppsych.2015.03.002

M3 - Article

C2 - 25799088

AN - SCOPUS:84930181610

VL - 37

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 3

ER -